Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation - Stock Option (Details)

v3.22.2.2
Share-Based Compensation - Stock Option (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Options Outstanding  
Granted (in shares) | shares 2,034,279
Outstanding and non-vested, ending balance (in shares) | shares 2,034,279
Weighted Average Exercise Price  
Granted (in dollar per share) | $ / shares $ 6.43
Outstanding and non-vested, ending balance (in dollar per share) | $ / shares $ 6.43
Weighted Average Remaining Contractual Life (Years)  
Granted 2 years 11 months 26 days
Outstanding 2 years 11 months 26 days
Options | Maximum  
Other disclosures  
Vesting period 5 years
Options | Minimum  
Other disclosures  
Vesting period 2 years
Performance-based options  
Number of Options Outstanding  
Granted (in shares) | shares 100,000
Weighted Average Exercise Price  
Granted (in dollar per share) | $ / shares $ 5.02
Other disclosures  
Compensation expense | $ $ 0